Clinical Trial Update: PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing PTCy-ATG versus ATG for graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation-related Graft-versus-host Disease Prophylaxis

Drugs mentioned

• ATG (anti-thymocyte globulin)
• PTCy-ATG

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Hematopoietic Stem Cell Transplantation | Phase 4 | Status: UNKNOWN